|
|
|
|
|
|
| Ductal Carcinoma in Situ |
| Etiology Unknown |
| Pathogenesis Some evidence that BRCA1 abnormalities already present in in situ disease See discussion of infilatrating duct carcinoma for more details., |
| Epidemiology Increasing age More frequent in women of low parity with first child after 30 Increased in obesity Increased in women with history of atypical hyperplasia Increased in women with history of breast carcinoma Increased in women with mother or sibling with breast cancer |
| General Gross Description May be associated with microcalcifications within the lumens Gross findings may be of fibrocystic change May form mass In comedo variant cysts (dilated ducts) are filled with granular, yellow white material May be associated with invasive carcinoma |
| General Microscopic Description There are several varieties including papillary (delicate fibrovascular cores covered with atypical cells), cribriform (multiple lumens within a single duct), solid, micropapillary (tiny epithelial papillae), comedo (around necrotic center) and clinging in which only one to two abnormal cell layers "cling" to the basement membrane. All show loss of typical bilayered epithelium All show enlarged round to oval nuclei with nucleoli; comedo variety typically shows nuclear pleomorphism, hyperchromasia, large nucleoli and mitotic activity All show loss of polarity towards lumen All types may show intraluminal microcalcifications |
| Clinical Correlation Increased risk of breast cancer 10 fold Lesions are generally extirpated surgically with clear margins |
| References Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th edition. Philadelphia, W.B. Saunders, 1994, pp. 1099-1108. Scully, R. et.al. Proc. Nat.Acad. Sci. 94(11): 5605-5610, 1997. |
| Ductal Carcinoma in Situ |
| Synopsis by: Melinda Sanders M.D. (T04000M85002)[305] |
| Search Medline at National Library of Medicine Please be patient during transfer. Medline will open in a new window. To return, close the Medline Window |
|
|
|
|
|
|